课题基金 / 基金详情

Arylhydrocarbon receptor in resistance to listeriosis

Arylhydrocarbon receptor in resistance to listeriosis
芳基烃受体抵抗李斯特菌病
批准号:
6872795
负责人:
CHARLES Joseph CZUPRYNSKI
金额:
$18.19万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-05-01 至 2007-04-30

项目摘要

项目成果

CHARLES Joseph CZUPRYNSKI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):李斯特菌病是一种重要的食源性疾病,在美国每年造成约2,500例严重疾病和多达500例死亡。对结核病的抵抗需要先天性和适应性免疫应答,前者依赖于炎性细胞因子TNF-α的释放以及粒细胞和单核吞噬细胞向感染部位的快速动员。芳香烃受体(aryl hydrocarbon receptor,AhR)是PAS碱性环螺旋蛋白家族的一个高度保守的成员。在脊椎动物中,当它被环境毒物如多氯代烃(如二恶英)和多环芳烃(如苯并[a]芘)激活时,它调节一个强大的信号系统。在无脊椎动物中,AhR参与环境感知,生物钟调节和正常发育,并且在脊椎动物中保留了其中的一些功能。AhR的激活可对免疫系统的各个方面具有有害影响,包括宿主对随后的微生物感染的防御。然而,AhR激活也导致TNF-α的释放,这是其一些生物学效应的原因。我们已经获得了令人兴奋的和挑衅性的初步数据表明,AhR无效小鼠比野生型小鼠对实验性阿尔茨海默病的抵抗力更低。本项目的总体目标是了解AhR如何影响对L.单核细胞增多症核心假设是AhR是针对原发性L的先天免疫的最佳发育和表达所必需的。单核细胞增多症感染,并且这涉及TNF-α的AhR依赖性释放。 本研究的具体目的是:1)确定AhR对小鼠抗疟原虫病的要求; 2)确定AhR是否影响L. 3)研究AhR对粒细胞和巨噬细胞抗肿瘤活性的影响。将确定TNF-α在所有3个目标中观察到的反应中的作用。在这项研究完成后,我们将有新的和重要的新见解的AhR参与天然免疫对L。单核细胞增多症这些研究可能会确定潜在的新靶点,用于增强对阿尔茨海默病的先天免疫,可能是通过施用AhR激动剂(类黄酮等),通过AhR发出信号,而不会引发环境毒物结合后的不良事件。
英文摘要
DESCRIPTION (provided by applicant): Listeriosis is an important food borne disease that causes approximately 2,500 cases of serious illness and as many as 500 deaths per year in the United States. Resistance to listedosis requires both innate and adaptive immune responses, with the former being dependent on release of the inflammatory cytokine TNF-alpha and the rapid mobilization of granulocytes and mononuclear phagocytes to sites of infection. The aryl hydrocarbon receptor (AhR) is a highly conserved member of the basic loop helix-PAS protein family. In vertebrates, it regulates a powerful signaling system when it is activated by environmental toxicants such as polychlorinated hydrocarbons (e.g. dioxin) and polycyclic aromatic hydrocarbons (e.g. benzo[a]pyrene). In invertebrates the AhR is involved in environmental sensing, regulation of biological clocks and normal development, and it retains some of these functions within vertebrates. Activation of the AhR can have a deleterious effect on various aspects of the immune system, including host defense against subsequent microbial infection. However, AhR activation also leads to release of TNF-alpha that is responsible for some of its biological effects. We have obtained exciting and provocative preliminary data indicating that AhR null mice are less resistant to experimental listeriosis than their wild type counterparts. The overall goal of this project is to understand how the AhR influences resistance to L. monocytogenes infection. The central hypothesis is that the AhR is required for optimal development and expression of innate immunity against a primary L. monocytogenes infection, and that this involves AhR dependent release of TNF-alpha. The specific aims of the proposal are as follows: 1) Define the requirement of the AhR for resistance to listeriosis in mice; 2) Determine whether the AhR influences the survival and multiplication of L. monocytogenes in hepatocytes; and 3) Investigate the effects of the AhR on the anti-listerial activity of granulocytes and macrophages. The role of TNF-alpha in the responses observed in all 3 aims will be determined. At the completion of this study, we will have novel and important new insights into the participation of the AhR in innate immunity against L. monocytogenes infection. These studies may identify potential new targets for enhancing innate immunity against listeriosis, perhaps by administration of AhR agonists (flavenoids, etc.), that signal through the AhR without triggering the adverse events that follow binding of environmental toxicants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reducing wound bioburden and biofilm formation using a nanoscale wound surface en
  • 批准号:
    8386272
  • 项目类别:
  • 资助金额:
    $18.81万
  • 财政年份:
    2012
  • 负责人:
    CHARLES Joseph CZUPRYNSKI
  • 依托单位:
Reducing wound bioburden and biofilm formation using a nanoscale wound surface en
  • 批准号:
    8518098
  • 项目类别:
  • 资助金额:
    $21.29万
  • 财政年份:
    2012
  • 负责人:
    CHARLES Joseph CZUPRYNSKI
  • 依托单位:
Comparative Biomedical Sciences Training Program
  • 批准号:
    8266731
  • 项目类别:
  • 资助金额:
    $30.76万
  • 财政年份:
    2007
  • 负责人:
    CHARLES Joseph CZUPRYNSKI
  • 依托单位:
Comparative Biomedical Sciences Training Program
  • 批准号:
    7456455
  • 项目类别:
  • 资助金额:
    $22.09万
  • 财政年份:
    2007
  • 负责人:
    CHARLES Joseph CZUPRYNSKI
  • 依托单位:
国内基金
海外基金
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
  • 批准号:
    82372202
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    侯旭敏
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位:
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
  • 批准号:
    82370797
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陶弢
  • 依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
  • 批准号:
    82370865
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    黄哲
  • 依托单位: